Traditionally, drug development arises from a university discovery for which a pharmaceutical company acquires the rights and thereafter navigates the path to market approval. This process of shepherding a therapeutic discovery to become a U.S. …
Month: July 2019
WARF Accelerator Award
SCRMC Faculty Member Peiman Hematti has been awarded a WARF Accelerator Project titled, “Development of Therapeutic Macrophages for Radiation Injuries.”